Manufacturer
Pharmacyclics
- Products listed
- 6
- Molecules
- 1
- Therapy areas
- 1
Pharmacyclics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 6 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Pharmacyclics LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Pharmacyclics products through licensed channels, with the documents your regulator needs.
Oncology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Imbruvica 140 mg tabletOral | Ibrutinib | US FDA | Available on request |
| Imbruvica 140 mg capsuleOral | Ibrutinib | US FDA | Available on request |
| Imbruvica 280 mg tabletOral | Ibrutinib | US FDA | Available on request |
| Imbruvica 420 mg tabletOral | Ibrutinib | US FDA | Available on request |
| Imbruvica 70 mg capsuleOral | Ibrutinib | US FDA | Available on request |
| Imbruvica 70 mg/mL oral suspensionOral | Ibrutinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Pharmacyclics
Send a request for any of these products. We confirm the licensed source, documents and lead time.